These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26319792)

  • 1. Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response.
    Rybtke M; Hultqvist LD; Givskov M; Tolker-Nielsen T
    J Mol Biol; 2015 Nov; 427(23):3628-45. PubMed ID: 26319792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bacterial biofilms in chronic infections.
    Bjarnsholt T
    APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
    Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
    Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
    Tolker-Nielsen T
    APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
    Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.
    Hengzhuang W; Høiby N; Ciofu O
    Methods Mol Biol; 2014; 1147():239-54. PubMed ID: 24664838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal.
    Harmsen M; Yang L; Pamp SJ; Tolker-Nielsen T
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):253-68. PubMed ID: 20497222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.
    Seth AK; Zhong A; Nguyen KT; Hong SJ; Leung KP; Galiano RD; Mustoe TA
    Wound Repair Regen; 2014; 22(6):712-9. PubMed ID: 25230854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay of Pseudomonas aeruginosa and Staphylococcus aureus in dual-species biofilms impacts development, antibiotic resistance and virulence of biofilms in in vitro wound infection models.
    Vestweber PK; Wächter J; Planz V; Jung N; Windbergs M
    PLoS One; 2024; 19(5):e0304491. PubMed ID: 38805522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.
    Ciofu O; Mandsberg LF; Wang H; Høiby N
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.
    Trøstrup H; Lerche CJ; Christophersen L; Jensen PØ; Høiby N; Moser C
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
    Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
    Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments.
    Thorn RM; Greenman J
    J Appl Microbiol; 2009 Dec; 107(6):2070-9. PubMed ID: 19548886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S; Karaaslan E
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
    Pye CC; Yu AA; Weese JS
    Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
    Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.